|
RECK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.02439970237367E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.12750000447193E-08 |
| Normal-vs-Stage2 |
8.994200E-04 |
| Normal-vs-Stage3 |
4.29419999559144E-08 |
| Normal-vs-Stage4 |
9.09199999954424E-07 |
| Stage1-vs-Stage2 |
5.769400E-01 |
| Stage1-vs-Stage3 |
4.359200E-01 |
| Stage1-vs-Stage4 |
4.071000E-01 |
| Stage2-vs-Stage3 |
3.183600E-01 |
| Stage2-vs-Stage4 |
3.012800E-01 |
| Stage3-vs-Stage4 |
8.251000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.0654999999834E-07 |
| Normal-vs-AfricanAmerican |
9.87449999999557E-05 |
| Normal-vs-Asian |
4.875200E-03 |
| Caucasian-vs-AfricanAmerican |
4.103400E-01 |
| Caucasian-vs-Asian |
9.275900E-02 |
| AfricanAmerican-vs-Asian |
1.098420E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.8822000003027E-07 |
| Normal-vs-Female |
9.80959979912654E-10 |
| Male-vs-Female |
9.292200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.55130000004211E-06 |
| Normal-vs-Age(41-60Yrs) |
2.609100047124E-09 |
| Normal-vs-Age(61-80Yrs) |
4.18149999958928E-07 |
| Normal-vs-Age(81-100Yrs) |
1.089770E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.321700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.452770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.161200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.779200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.800600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.043400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.870390E-01 |
| Classical-VS-Follicular |
7.080400E-01 |
| Classical-VS-Other |
4.778800E-01 |
| Classical-VS-Normal |
2.81380000000109E-06 |
| Tall-VS-Follicular |
3.725600E-01 |
| Tall-VS-Other |
9.715800E-01 |
| Tall-VS-Normal |
2.04640000001088E-06 |
| Follicular-VS-Other |
6.180800E-01 |
| Follicular-VS-Normal |
4.53199999994602E-06 |
| Other-VS-Normal |
1.820090E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.43339999980618E-07 |
| Normal-vs-N1 |
2.557899999589E-07 |
| N0-vs-N1 |
3.460200E-01 |
|
|
